Thursday, 31 December 2009

Cayston




In the US, Cayston (aztreonam systemic) is a member of the drug class miscellaneous antibiotics and is used to treat Cystic Fibrosis and Pneumonia with Cystic Fibrosis.

US matches:

  • Cayston

  • Cayston inhalation

UK matches:

  • Cayston 75 mg powder and solvent for nebuliser solution (SPC)

Ingredient matches for Cayston



Aztreonam

Aztreonam is reported as an ingredient of Cayston in the following countries:


  • Canada

  • Germany

  • Ireland

  • Netherlands

  • United Kingdom

  • United States

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sulfathiazole




In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

D06BA02,J01EB07

CAS registry number (Chemical Abstracts Service)

0000072-14-0

Chemical Formula

C9-H9-N3-O2-S2

Molecular Weight

255

Therapeutic Category

Antibacterial: Sulfonamid

Chemical Name

Benzenesulfonamide, 4-amino-N-2-thiazolyl-

Foreign Names

  • Sulfathiazolum (Latin)
  • Sulfathiazol (German)
  • Sulfathiazol (French)
  • Sulfatiazol (Spanish)

Generic Names

  • Sulfathiazol (OS: DCF)
  • Sulfathiazole (OS: BAN)
  • Sulfatiazolo (OS: DCIT)
  • Ciba 3714 (IS)
  • M & B 760 (IS)
  • Norsulfazolum (IS)
  • RP 2090 (IS)
  • Septozol (IS)
  • Sulphathiazole (IS)
  • Sulfathiazol (PH: Ph. Eur. 6)
  • Sulfathiazole (PH: BP 2010, USP 32, Ph. Eur. 6)
  • Sulfathiazolum (PH: Ph. Int. 2, Ph. Eur. 6)
  • Sulfathiazole Sodium (OS: BANM)
  • Sulphathiazole Sodium (IS)
  • Sulfathiazole Sodium (PH: USP 30, BP vet. 2007)
  • Sulfathiazolum Natricum (PH: Ph. Int. 2)

Brand Names

  • Argosulfan
    Jelfa, Bulgaria; Jelfa, Georgia; Jelfa, Hungary; Jelfa, Lithuania; Jelfa, Latvia; Jelfa, Russian Federation


  • Aureozol (Sulfathiazole and Chlortetracycline + Benzylpenicillin (veterinary use))
    Alpharma Animal Health, United States


  • B-TS Trio (Sulfathiazole and Sulfadimidine, + Trimethoprim (veterinary use))
    Biokema, Switzerland


  • CSP (Sulfathiazole and Chlortetracycline + Benzylpenicillin (veterinary use))
    Alpharma Animal Health, United States


  • Medivet Trio S (Sulfathiazole and Trimethoprim, + Sulfadimidine (veterinary use))
    Medivet, Switzerland


  • Panazolin (Sulfathiazole and Sulfadimidine (veterinary use))
    Gräub, Switzerland


  • Rhinolex (Sulfathiazole andEphedrine hydrochloride)
    Sopharma, Bulgaria


  • Sulfa 3 (Sulfathiazole and Sulfadimidine, + Sulfamerazine (veterinary use))
    IncaFlight, Australia


  • Sulfarinol (Sulfathiazole and Naphazolin Nitrate)
    Galenus, Poland


  • Sulfatiazol Cifsa
    Cifsa, Ecuador


  • Sulfatiazol
    Fecofar, Argentina


  • Triperos (Sulfathiazole and Sulfadiazine, + Sulfadimidine (veterinary use))
    Gräub, Switzerland


  • UFA 902 DUO (Sulfathiazole and Sulfadimidine, + Trimethoprim (veterinary use))
    Ufamed, Switzerland


  • Vetoprim (Sulfathiazole and Sulfadimidine, + Trimethoprim (veterinary use))
    Essex Tierarzneimittel, Germany


  • Vital TSS (Sulfathiazole and Sulfadimidine, + Trimethoprim (veterinary use))
    Vital, Switzerland


  • Welt-Sulfazol
    Welt, Argentina


  • Argosulfan
    Jelfa, Poland

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 24 December 2009

Anasma




Anasma may be available in the countries listed below.


Ingredient matches for Anasma



Fluticasone

Fluticasone propionate (a derivative of Fluticasone) is reported as an ingredient of Anasma in the following countries:


  • Spain

Salmeterol

Salmeterol xinafoate (a derivative of Salmeterol) is reported as an ingredient of Anasma in the following countries:


  • Spain

International Drug Name Search

Tuesday, 22 December 2009

Atenolol Heumann




Atenolol Heumann may be available in the countries listed below.


Ingredient matches for Atenolol Heumann



Atenolol

Atenolol is reported as an ingredient of Atenolol Heumann in the following countries:


  • Germany

International Drug Name Search

Monday, 21 December 2009

Losartan Winthrop




Losartan Winthrop may be available in the countries listed below.


Ingredient matches for Losartan Winthrop



Losartan

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Losartan Winthrop in the following countries:


  • Germany

  • Spain

International Drug Name Search

Sandoz Fluoxetine




Sandoz Fluoxetine may be available in the countries listed below.


Ingredient matches for Sandoz Fluoxetine



Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Sandoz Fluoxetine in the following countries:


  • Canada

  • South Africa

International Drug Name Search

Sunday, 13 December 2009

Biociclin




Biociclin may be available in the countries listed below.


Ingredient matches for Biociclin



Cefuroxime

Cefuroxime sodium salt (a derivative of Cefuroxime) is reported as an ingredient of Biociclin in the following countries:


  • Italy

International Drug Name Search

Negortire




Negortire may be available in the countries listed below.


Ingredient matches for Negortire



Epoetin Alfa

Epoetin Alfa is reported as an ingredient of Negortire in the following countries:


  • Mexico

International Drug Name Search

Saturday, 12 December 2009

Ketamin Cristalia




Ketamin Cristalia may be available in the countries listed below.


Ingredient matches for Ketamin Cristalia



Ketamine

Ketamine is reported as an ingredient of Ketamin Cristalia in the following countries:


  • Peru

International Drug Name Search

Wednesday, 9 December 2009

Fentanyl J-C




Fentanyl J-C may be available in the countries listed below.


Ingredient matches for Fentanyl J-C



Fentanyl

Fentanyl is reported as an ingredient of Fentanyl J-C in the following countries:


  • Netherlands

International Drug Name Search

Monday, 7 December 2009

Novesin




Novesin may be available in the countries listed below.


Ingredient matches for Novesin



Oxybuprocaine

Oxybuprocaine hydrochloride (a derivative of Oxybuprocaine) is reported as an ingredient of Novesin in the following countries:


  • Bangladesh

  • Czech Republic

  • Oman

  • Switzerland

  • Taiwan

International Drug Name Search

Thursday, 3 December 2009

Fungonazol




Fungonazol may be available in the countries listed below.


Ingredient matches for Fungonazol



Itraconazole

Itraconazole is reported as an ingredient of Fungonazol in the following countries:


  • Greece

International Drug Name Search

Wednesday, 2 December 2009

Rhinotrophyl




Rhinotrophyl may be available in the countries listed below.


Ingredient matches for Rhinotrophyl



Tenoic Acid

Tenoic Acid is reported as an ingredient of Rhinotrophyl in the following countries:


  • France

International Drug Name Search

Oseomax




Oseomax may be available in the countries listed below.


Ingredient matches for Oseomax



Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Oseomax in the following countries:


  • Dominican Republic

International Drug Name Search

Monday, 30 November 2009

Bronkolin




Bronkolin may be available in the countries listed below.


Ingredient matches for Bronkolin



Theophylline

Theophylline is reported as an ingredient of Bronkolin in the following countries:


  • Turkey

International Drug Name Search

Saturday, 28 November 2009

Starval




Starval may be available in the countries listed below.


Ingredient matches for Starval



Valsartan

Valsartan is reported as an ingredient of Starval in the following countries:


  • India

  • Peru

International Drug Name Search

Friday, 27 November 2009

Pancuronium Inresa




Pancuronium Inresa may be available in the countries listed below.


Ingredient matches for Pancuronium Inresa



Pancuronium

Pancuronium Bromide is reported as an ingredient of Pancuronium Inresa in the following countries:


  • Germany

International Drug Name Search

Wednesday, 25 November 2009

Initiss




Initiss may be available in the countries listed below.


Ingredient matches for Initiss



Cilazapril

Cilazapril is reported as an ingredient of Initiss in the following countries:


  • Italy

International Drug Name Search

Sodium Benzoate




Sodium Benzoate may be available in the countries listed below.


Ingredient matches for Sodium Benzoate



Benzoic Acid

Sodium Benzoate (JAN, USAN) is known as Benzoic Acid in the US.

International Drug Name Search

Glossary

JANJapanese Accepted Name
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday, 23 November 2009

Triaderm




Triaderm may be available in the countries listed below.


Ingredient matches for Triaderm



Triamcinolone

Triamcinolone 16α,17α-acetonide (a derivative of Triamcinolone) is reported as an ingredient of Triaderm in the following countries:


  • Canada

International Drug Name Search

Wednesday, 18 November 2009

Januvia


Januvia is a brand name of sitagliptin, approved by the FDA in the following formulation(s):


JANUVIA (sitagliptin phosphate - tablet; oral)



  • Manufacturer: MERCK CO INC

    Approval date: October 16, 2006

    Strength(s): EQ 100MG BASE [RLD], EQ 25MG BASE, EQ 50MG BASE

Has a generic version of Januvia been approved?


No. There is currently no therapeutically equivalent version of Januvia available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Januvia. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Use of dipeptidyl peptidase IV effectors for lowering the blood glucose level in mammals
    Patent 6,303,661
    Issued: October 16, 2001
    Inventor(s): Demuth; Hans-Ulrich & Rosche; Fred & Schmidt; Joem & Pauly; Robert P. & McIntosh; Christopher H. S. & Pederson; Ray A.
    Assignee(s): Probiodrug
    Novel therapeutic regimens are provided which comprise the administration of therapeutically effective amounts of an inhibitor to dipeptidyl peptidase (DP-IV) or enzymes of similar activity whereby their ability to degrade the incretins, GLP-1 and GIP, is reduced. As a result hyperglycemia, such as that accompanying food intake may be reduced due to improved insulin release. A preferred therapeutic regimen amongst a number of routes of administration and inhibitors that may be used comprises the oral administration of isoleucyl thiazolidine.
    Patent expiration dates:

    • April 24, 2017
      ✓ 
      Patent use: METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASTE-IV INHIBITOR




  • Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
    Patent 6,699,871
    Issued: March 2, 2004
    Inventor(s): Scott D.; Edmondson & Michael H.; Fisher & Dooseop; Kim & Malcolm; Maccoss & Emma R.; Parmee & Ann E.; Weber & Jinyou; Xu
    Assignee(s): Merck & Co., Inc.
    The present invention is directed to compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
    Patent expiration dates:

    • July 26, 2022
      ✓ 
      Patent use: METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASTE-IV INHIBITOR
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Method of regulating glucose metabolism, and reagents related thereto
    Patent 6,890,898
    Issued: May 10, 2005
    Inventor(s): Bachovchin; William W. & Plaut; Andrew G. & Drucker; Daniel
    Assignee(s): Trustees of Tufts College
    1149336 Ontario Inc.
    New England Medical Center Hospitals, Inc.
    The present invention provides methods and compositions for modification and regulation of glucose and lipid metabolism, generally to reduce insulin resistance, hyperglycemia, hyperinsulinemia, obesity, hyperlipidemia, hyperlipoprotein-emia (such as chylomicrons, VLDL and LDL), and to regulate body fat and more generally lipid stores, and, more generally, for the improvement of metabolism disorders, especially those associated with diabetes, obesity and/or atherosclerosis.
    Patent expiration dates:

    • February 2, 2019
      ✓ 
      Patent use: METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR IN COMBINATION WITH METFORMIN AND/OR A SULFONYLUREA


    • February 2, 2019
      ✓ 
      Patent use: METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-4 INHIBITOR IN COMBINATION WITH METFORMIN


    • February 2, 2019
      ✓ 
      Patent use: METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-4 INHIBITOR IN COMBINATION WITH INSULIN




  • Method of regulating glucose metabolism, and reagents related thereto
    Patent 7,078,381
    Issued: July 18, 2006
    Inventor(s): Bachovchin; William W. & Plaut; Andrew G. & Drucker; Daniel
    Assignee(s): Trustees of Tufts College
    The present invention provides methods and compositions for modifying glucose metabolism and treating Type II diabetes in an animal, along with modifying metabolism of a peptide hormone in an animal. Compositions disclosed herein comprise one or more peptides and/or peptide analogs which include a functional group that reacts with an active site residue of a protease.
    Patent expiration dates:

    • February 2, 2019
      ✓ 
      Patent use: METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-4 INHIBITOR IN COMBINATION WITH METFORMIN AND A PPAR-GAMMA AGONIST


    • February 2, 2019
      ✓ 
      Patent use: METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR IN COMBINATION WITH METFORMIN AND/OR A SULFONYLUREA


    • February 2, 2019
      ✓ 
      Patent use: METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-4 INHIBITOR IN COMBINATION WITH INSULIN


    • February 2, 2019
      ✓ 
      Patent use: METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR IN COMBINATION WITH A PPAR-GAMMA AGONIST




  • Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
    Patent 7,125,873
    Issued: October 24, 2006
    Inventor(s): Edmondson; Scott D & Fisher; Michael H. & Kim; Dooseop & Maccoss; Malcolm & Parmee; Emma R. & Weber; Ann E & Xu; Jinyou
    Assignee(s): Merck & Co., Inc.
    The present invention is directed to compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
    Patent expiration dates:

    • July 26, 2022
      ✓ 
      Patent use: METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-4 INHIBITOR IN COMBINATION WITH METFORMIN AND A PPAR-GAMMA AGONIST


    • July 26, 2022
      ✓ 
      Patent use: METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR IN COMBINATION WITH METFORMIN AND/OR A SULFONYLUREA


    • July 26, 2022
      ✓ 
      Patent use: METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR IN COMBINATION WITH A PPAR-GAMMA AGONIST


    • July 26, 2022
      ✓ 
      Patent use: METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-4 INHIBITOR IN COMBINATION WITH INSULIN




  • Phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor
    Patent 7,326,708
    Issued: February 5, 2008
    Inventor(s): Cypes; Stephen Howard & Chen; Alex Minhua & Ferlita; Russell R. & Hansen; Karl & Lee; Ivan & Vydra; Vicky K. & Wenslow, Jr.; Robert M.
    Assignee(s): Merck & Co., Inc.
    The dihydrogenphosphate salt of 4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine is a potent inhibitor of dipeptidyl peptidase-IV and is useful for the prevention and/or treatment of non-insulin dependent diabetes mellitus, also referred to as type 2 diabetes. The invention also relates to a crystalline monohydrate of the dihydrogenphosphate salt as well as a process for its preparation, pharmaceutical compositions containing this novel form and methods of use for the treatment of diabetes, obesity, and high blood pressure.
    Patent expiration dates:

    • April 11, 2026
      ✓ 
      Patent use: METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR
      ✓ 
      Drug substance
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • October 12, 2010 - DESCRIPTION OF RESULTS OF STUDY OF INITIAL THERAPY IN COMBINATION WITH METFORMIN WHEN DIET AND EXERCISE DO NOT PROVIDE GLYCEMIC CONTROL

    • October 12, 2010 - RESULTS OF STUDY OF COMBINATION THERAPY AND NON-INFERIORITY STUDY

    • October 16, 2011 - NEW CHEMICAL ENTITY

See also...

  • Januvia Consumer Information (Drugs.com)
  • Januvia Consumer Information (Wolters Kluwer)
  • Januvia Consumer Information (Cerner Multum)
  • Januvia Advanced Consumer Information (Micromedex)
  • Januvia AHFS DI Monographs (ASHP)
  • Sitagliptin Consumer Information (Wolters Kluwer)
  • Sitagliptin Consumer Information (Cerner Multum)
  • Sitagliptin Advanced Consumer Information (Micromedex)
  • Sitagliptin Phosphate AHFS DI Monographs (ASHP)

Monday, 16 November 2009

Doramectin




In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0117704-25-3

Chemical Formula

C50-H74-O14

Molecular Weight

899

Therapeutic Categories

Anthelmintic

Ectoparasiticide

Chemical Name

Avermectin A₁a, 25-cyclohexyl-5-O-demethyl-25-de(1-methylpropyl)-

Foreign Names

  • Doramectinum (Latin)
  • Doramectin (German)
  • Doramectine (French)
  • Doramectina (Spanish)

Generic Names

  • Doramectin (OS: USAN, BAN)
  • UK 67994 (IS: Pfizer)

Brand Names

  • Dectomax (veterinary use)
    Botéba, Netherlands; Novivet, Netherlands; Orion, Sweden; Pfizer, Austria; Pfizer, Poland; Pfizer Animal, Portugal; Pfizer Animal Health, Australia; Pfizer Animal Health, Belgium; Pfizer Animal Health, Switzerland; Pfizer Animal Health, Finland; Pfizer Animal Health, United Kingdom; Pfizer Animal Health, Ireland; Pfizer Animal Health, Italy; Pfizer Animal Health, Luxembourg; Pfizer Animal Health, Netherlands; Pfizer Animal Health, Norway; Pfizer Animal Health, New Zealand; Pfizer Animal Health, United States; Pfizer Animal Health, South Africa; Pfizer GmbH Tiergesundheit, Germany; Pfizer Santé Animale, France


  • Dectomax-S (veterinary use)
    Pfizer GmbH Tiergesundheit, Germany


  • Prontax (veterinary use)
    Pfizer Animal Health, Netherlands

International Drug Name Search

Glossary

BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 15 November 2009

Mevalotin




Mevalotin may be available in the countries listed below.


Ingredient matches for Mevalotin



Pravastatin

Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Mevalotin in the following countries:


  • Brazil

  • China

  • Germany

  • Japan

  • Switzerland

  • Taiwan

  • Venezuela

International Drug Name Search

Your Pharmacy Aciclovir




Your Pharmacy Aciclovir may be available in the countries listed below.


Ingredient matches for Your Pharmacy Aciclovir



Acyclovir

Aciclovir is reported as an ingredient of Your Pharmacy Aciclovir in the following countries:


  • Australia

International Drug Name Search

Saturday, 14 November 2009

Bexatus




Bexatus may be available in the countries listed below.


Ingredient matches for Bexatus



Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Bexatus in the following countries:


  • Spain

International Drug Name Search

Purinol




Purinol may be available in the countries listed below.


Ingredient matches for Purinol



Allopurinol

Allopurinol is reported as an ingredient of Purinol in the following countries:


  • Austria

  • Czech Republic

  • Ireland

  • Oman

  • Russian Federation

  • Tunisia

Methenamine

Methenamine anhydromethylencitrate (a derivative of Methenamine) is reported as an ingredient of Purinol in the following countries:


  • Turkey

International Drug Name Search

Friday, 13 November 2009

dorzolamide ophthalmic


Generic Name: dorzolamide ophthalmic (dor ZOL a mide)

Brand Names: Trusopt


What is dorzolamide ophthalmic?

Dorzolamide reduces the amount of fluid in the eye, which decreases pressure inside the eye.


Dorzolamide ophthalmic (for the eyes) is used to treat open-angle glaucoma and other causes of high pressure inside the eye.

Dorzolamide ophthalmic may also be used for purposes not listed in this medication guide.


What is the most important information I should know about dorzolamide ophthalmic?


Do not allow the dropper to touch any surface, including the eyes or hands. If the dropper becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye.

Do not use any other eye medication unless your doctor has prescribed it for you. If you use another eye medication, use it at least 10 minutes before or after using dorzolamide ophthalmic. Do not use the medications at the same time.


Dorzolamide ophthalmic can cause blurred vision. Be careful if you drive or do anything that requires you to be able to see clearly.

What should I discuss with my healthcare provider before using dorzolamide ophthalmic?


You should not use this medication if you are allergic to dorzolamide (Trusopt or Cosopt).

To make sure you can safely use dorzolamide ophthalmic, tell your doctor if you have any of these other conditions:



  • narrow-angle glaucoma;




  • kidney disease; or




  • liver disease.




FDA pregnancy category C. It is not known whether dorzolamide ophthalmic will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. It is not known whether dorzolamide ophthalmic passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I use dorzolamide ophthalmic?


Use exactly as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.


Do not use this medication while wearing contact lenses. Dorzolamide ophthalmic may contain a preservative that can discolor soft contact lenses. Wait at least 15 minutes after using dorzolamide before putting your contact lenses in.

This medication comes with patient instructions for safe and effective use. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.


Wash your hands before using the eye drops.

To apply the eye drops:



  • Tilt your head back slightly and pull down your lower eyelid to create a small pocket. Hold the dropper above the eye with the tip down. Look up and away from the dropper as you squeeze out a drop, then close your eye.




  • Use only the number of drops your doctor has prescribed.




  • Gently press your finger to the inside corner of the eye (near your nose) for about 1 minute to keep the liquid from draining into your tear duct.




  • If you use more than one drop in the same eye, wait about 5 minutes before putting in the next drop.




  • Wait at least 10 minutes before using any other eye drops that your doctor has prescribed.




Do not allow the dropper tip to touch any surface, including the eyes or hands. If the dropper becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye.

Do not use the eye drops if the liquid has changed colors or has particles in it. Call your doctor for a new prescription.


Tell your doctor right away if you have any eye injury or infection, or if you need to have any type of surgery, especially eye surgery. You may need to stop using dorzolamide ophthalmic for a short time.


Store at room temperature away from moisture, heat, and light. Keep the bottle tightly closed when not in use.

What happens if I miss a dose?


Use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Overdose symptoms may include dry mouth, increased thirst, drowsiness, restless feeling, confusion, nausea, vomiting, increased urination, muscle pain or weakness, fast heart rate, feeling light-headed, fainting, or seizure (convulsions).


What should I avoid while using dorzolamide ophthalmic?


Dorzolamide ophthalmic may cause blurred vision. Be careful if you drive or do anything that requires you to be able to see clearly.

Do not use other eye medications during treatment with dorzolamide ophthalmic unless your doctor tells you to.


Dorzolamide ophthalmic side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Although the risk of serious side effects is low when dorzolamide is used in the eyes, you should be aware of side effects that can occur if the medication is absorbed into your bloodstream.


Stop using dorzolamide ophthalmic and call your doctor at once if you have a serious side effect such as:

  • swelling or redness of your eyelids;




  • eye redness, pain, discomfort, or sensitivity to light;




  • drainage, crusting, or oozing of your eyes or eyelids;




  • severe skin reaction: fever, sore throat, swelling in your face or tongue, burning in your eyes, skin pain, followed by a red or purple skin rash that spreads (especially in the face or upper body) and causes blistering and peeling; or




  • stomach pain, loss of appetite, dark urine, jaundice (yellowing of the skin or eyes).



Less serious side effects may include:



  • burning or stinging in your eye;




  • bitter or unusual taste in your mouth;




  • blurred vision;




  • dry or watery eyes;




  • headache;




  • weakness, tired feeling;




  • nausea; or




  • dry mouth, sore throat.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


Dorzolamide ophthalmic Dosing Information


Usual Adult Dose for Intraocular Hypertension:

Instill 1 drop in the affected eye(s) 3 times daily.

Usual Adult Dose for Glaucoma (Open Angle):

Instill 1 drop in the affected eye(s) 3 times daily.

Usual Pediatric Dose for Intraocular Hypertension:

Instill 1 drop in the affected eye(s) 3 times daily.

Usual Pediatric Dose for Glaucoma (Open Angle):

Instill 1 drop in the affected eye(s) 3 times daily.


What other drugs will affect dorzolamide ophthalmic?


Tell your doctor about all other medicines you use, especially:



  • acetazolamide (Diamox);




  • brinzolamide (Azopt); or




  • methazolamide (Neptazane).



This list is not complete and other drugs may interact with dorzolamide ophthalmic. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More dorzolamide ophthalmic resources


  • Dorzolamide ophthalmic Side Effects (in more detail)
  • Dorzolamide ophthalmic Dosage
  • Dorzolamide ophthalmic Use in Pregnancy & Breastfeeding
  • Dorzolamide ophthalmic Drug Interactions
  • Dorzolamide ophthalmic Support Group
  • 0 Reviews for Dorzolamide - Add your own review/rating


  • Trusopt Prescribing Information (FDA)

  • Trusopt Monograph (AHFS DI)

  • Trusopt Drops MedFacts Consumer Leaflet (Wolters Kluwer)



Compare dorzolamide ophthalmic with other medications


  • Glaucoma, Open Angle
  • Intraocular Hypertension


Where can I get more information?


  • Your pharmacist can provide more information about dorzolamide ophthalmic.

See also: dorzolamide side effects (in more detail)


Tuesday, 10 November 2009

Co-Tensiol




Co-Tensiol may be available in the countries listed below.


Ingredient matches for Co-Tensiol



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Co-Tensiol in the following countries:


  • Slovenia

Olmesartan

Olmesartan Medoxomil is reported as an ingredient of Co-Tensiol in the following countries:


  • Slovenia

International Drug Name Search

Monday, 9 November 2009

Espesil




Espesil may be available in the countries listed below.


Ingredient matches for Espesil



Acebutolol

Acebutolol hydrochloride (a derivative of Acebutolol) is reported as an ingredient of Espesil in the following countries:


  • Finland

International Drug Name Search

Sunday, 8 November 2009

Cetrifarm




Cetrifarm may be available in the countries listed below.


Ingredient matches for Cetrifarm



Cetrimide

Cetrimide is reported as an ingredient of Cetrifarm in the following countries:


  • Italy

Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Cetrifarm in the following countries:


  • Italy

International Drug Name Search

Orystor




Orystor may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Orystor



Fenbendazole

Fenbendazole is reported as an ingredient of Orystor in the following countries:


  • Germany

International Drug Name Search

Monday, 2 November 2009

Desonate


Generic Name: desonide topical (DES oh nide)

Brand Names: Delonide, Desonate, DesOwen, DesOwen 2 oz, DesOwen Lotion 4 oz Kit, LoKara, Tridesilon, Verdeso


What is desonide topical?

Desonide is a topical (for the skin) steroid. It reduces the actions of chemicals in the body that cause inflammation, redness, and swelling.


Desonide topical is used to treat the inflammation and itching caused by a number of skin conditions such as allergic reactions, eczema, and psoriasis.


Desonide topical may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about desonide topical?


Use this medication exactly as directed on the label, or as it has been prescribed by your doctor. Do not use the medication in larger amounts or for longer than recommended. Topical steroid medicine can be absorbed through the skin, which may cause steroid side effects throughout the body.


Do not cover treated skin areas with a bandage or other covering unless your doctor has told you to. If you are treating the diaper area of a baby, do not use plastic pants or tight-fitting diapers. Covering the skin that is treated with desonide topical can increase the amount of medicine your skin absorbs, which may lead to unwanted side effects. Follow your doctor's instructions. Do not use this medication on a child without a doctor's advice. Children are more likely to absorb large amounts of a topical steroid through the skin. Steroid absorption in children may cause unwanted side effects, or a delay in growth with long-term use. Talk with your doctor if you think your child is not growing at a normal rate while using this medication over a long treatment period. Contact your doctor if your condition does not improve after 2 weeks of using this medicine, or if you develop signs of a bacterial, fungal, or viral skin infection.

What should I discuss with my healthcare provider before using desonide topical?


Do not use this medication if you are allergic to desonide.

Before using desonide topical, tell your doctor if you are allergic to any drugs, or if you have any type of skin infection.


Also tell your doctor if you have diabetes. Topical steroid medicines absorbed through the skin may increase the glucose (sugar) levels in your blood or urine.


FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether desonide topical passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Do not use this medication on a child without a doctor's advice. Children are more likely to absorb large amounts of a topical steroid through the skin. Steroid absorption in children may cause unwanted side effects, or a delay in growth with long-term use. Talk with your doctor if you think your child is not growing at a normal rate while using this medication over a long treatment period.

How should I use desonide topical?


Use this medication exactly as directed on the label, or as it has been prescribed by your doctor. Do not use the medication in larger amounts or for longer than recommended. Topical steroid medicine can be absorbed through the skin, which may cause steroid side effects throughout the body.


Wash your hands before and after using desonide topical, unless you are using the medication to treat the skin on your hands.

Apply a small amount to the affected area and rub it gently into the skin. Do not use this medication over a large area of skin.


Do not cover treated skin areas with a bandage or other covering unless your doctor has told you to. If you are treating the diaper area of a baby, do not use plastic pants or tight-fitting diapers. Covering the skin that is treated with desonide topical can increase the amount of medicine your skin absorbs, which may lead to unwanted side effects. Follow your doctor's instructions. Contact your doctor if your condition does not improve after 2 weeks of using this medicine, or if you develop signs of a bacterial, fungal, or viral skin infection. It is important to use desonide topical regularly to get the most benefit.

To be sure this medication is not causing harmful effects with long-term use, you may need blood tests. Do not miss any scheduled appointments.


Store desonide topical at room temperature away from moisture and heat. Keep from freezing.

What happens if I miss a dose?


Use the medication as soon as you remember. If it is almost time for the next dose, skip the missed dose and use the medicine at the next regularly scheduled time. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine.

An overdose of desonide is not expected to produce life-threatening symptoms. However, long-term use of high steroid doses can lead to symptoms such as thinning skin, easy bruising, changes in the shape or location of body fat (especially in your face, neck, back, and waist), increased acne or facial hair, menstrual problems, impotence, or loss of interest in sex.


What should I avoid while using desonide topical?


Desonide topical should not be used to treat any skin condition your doctor has not prescribed it for.


Avoid getting this medication in your eyes. If contact does occur, rinse with water. Do not use desonide topical on broken or infected skin. Also avoid using this medication in open wounds.

Desonide topical side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have severe irritation of any treated skin, or if you show signs of absorbing desonide topical through your skin, such as:

  • blurred vision, or seeing halos around lights;




  • mood changes;




  • sleep problems (insomnia);




  • weight gain, puffiness in your face; or




  • muscle weakness, feeling tired.



Less serious side effects may include:



  • mild skin itching, redness, burning, or peeling;




  • dryness or scaly skin;




  • thinning or softening of your skin;




  • skin rash or irritation around your mouth;




  • swollen hair follicles;




  • changes in color of treated skin;




  • blisters, pimples, or crusting of treated skin; or




  • stretch marks.



This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect desonide topical?


It is not likely that other drugs you take orally or inject will have an effect on topically applied desonide topical. But many drugs can interact with each other. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More Desonate resources


  • Desonate Side Effects (in more detail)
  • Desonate Use in Pregnancy & Breastfeeding
  • Desonate Drug Interactions
  • Desonate Support Group
  • 0 Reviews for Desonate - Add your own review/rating


  • Desonate Prescribing Information (FDA)

  • Desonate Gel MedFacts Consumer Leaflet (Wolters Kluwer)

  • Desonate Advanced Consumer (Micromedex) - Includes Dosage Information

  • Desonate Consumer Overview

  • DesOwen Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • DesOwen Cream Kit Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • Desowen Prescribing Information (FDA)

  • LoKara Prescribing Information (FDA)

  • LoKara Lotion MedFacts Consumer Leaflet (Wolters Kluwer)

  • Verdeso Prescribing Information (FDA)

  • Verdeso Consumer Overview

  • Verdeso Foam MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Desonate with other medications


  • Atopic Dermatitis
  • Dermatitis
  • Eczema
  • Psoriasis


Where can I get more information?


  • Your pharmacist can provide more information about desonide topical.

See also: Desonate side effects (in more detail)


Tuesday, 27 October 2009

Sterile Dopamin Concentrate




Sterile Dopamin Concentrate may be available in the countries listed below.


Ingredient matches for Sterile Dopamin Concentrate



Dopamine

Dopamine hydrochloride (a derivative of Dopamine) is reported as an ingredient of Sterile Dopamin Concentrate in the following countries:


  • New Zealand

  • United Kingdom

International Drug Name Search

Sunday, 18 October 2009

Pluspiryna




Pluspiryna may be available in the countries listed below.


Ingredient matches for Pluspiryna



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Pluspiryna in the following countries:


  • Poland

Caffeine

Caffeine is reported as an ingredient of Pluspiryna in the following countries:


  • Poland

International Drug Name Search

Saturday, 17 October 2009

Magacil




Magacil may be available in the countries listed below.


Ingredient matches for Magacil



Magaldrate

Magaldrate is reported as an ingredient of Magacil in the following countries:


  • Bangladesh

International Drug Name Search

Saturday, 10 October 2009

Urfamycine




Urfamycine may be available in the countries listed below.


Ingredient matches for Urfamycine



Thiamphenicol

Thiamphenicol is reported as an ingredient of Urfamycine in the following countries:


  • Luxembourg

Thiamphenicol glycinate hydrochloride (a derivative of Thiamphenicol) is reported as an ingredient of Urfamycine in the following countries:


  • Belgium

International Drug Name Search

Sunday, 4 October 2009

Selegiline HCl




Selegiline HCl may be available in the countries listed below.


Ingredient matches for Selegiline HCl



Selegiline

Selegiline hydrochloride (a derivative of Selegiline) is reported as an ingredient of Selegiline HCl in the following countries:


  • Japan

International Drug Name Search

Gutarhyde




Gutarhyde may be available in the countries listed below.


Ingredient matches for Gutarhyde



Glutaral

Glutaral is reported as an ingredient of Gutarhyde in the following countries:


  • Japan

International Drug Name Search

Friday, 25 September 2009

Gastromins




Gastromins may be available in the countries listed below.


Ingredient matches for Gastromins



Mebeverine

Mebeverine hydrochloride (a derivative of Mebeverine) is reported as an ingredient of Gastromins in the following countries:


  • Greece

International Drug Name Search

Lisiprol




Lisiprol may be available in the countries listed below.


Ingredient matches for Lisiprol



Lisinopril

Lisinopril is reported as an ingredient of Lisiprol in the following countries:


  • Poland

International Drug Name Search

Wednesday, 23 September 2009

Terfina




Terfina may be available in the countries listed below.


Ingredient matches for Terfina



Terbinafine

Terbinafine is reported as an ingredient of Terfina in the following countries:


  • Oman

International Drug Name Search

Tuesday, 22 September 2009

Terbinafina Hexal




Terbinafina Hexal may be available in the countries listed below.


Ingredient matches for Terbinafina Hexal



Terbinafine

Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of Terbinafina Hexal in the following countries:


  • Italy

International Drug Name Search

Saturday, 19 September 2009

Tierlite




Tierlite may be available in the countries listed below.


Ingredient matches for Tierlite



Fluconazole

Fluconazole is reported as an ingredient of Tierlite in the following countries:


  • Greece

International Drug Name Search

Wednesday, 16 September 2009

Betahistin Stada




Betahistin Stada may be available in the countries listed below.


Ingredient matches for Betahistin Stada



Betahistine

Betahistine dimesilate (a derivative of Betahistine) is reported as an ingredient of Betahistin Stada in the following countries:


  • Germany

International Drug Name Search

Sunday, 13 September 2009

Kathricol




Kathricol may be available in the countries listed below.


Ingredient matches for Kathricol



Ketotifen

Ketotifen fumarate (a derivative of Ketotifen) is reported as an ingredient of Kathricol in the following countries:


  • Greece

International Drug Name Search

Wednesday, 9 September 2009

Devalud




Devalud may be available in the countries listed below.


Ingredient matches for Devalud



Tizanidine

Tizanidine hydrochloride (a derivative of Tizanidine) is reported as an ingredient of Devalud in the following countries:


  • Turkey

International Drug Name Search

Monday, 7 September 2009

Goutichine




Goutichine may be available in the countries listed below.


Ingredient matches for Goutichine



Colchicine

Colchicine is reported as an ingredient of Goutichine in the following countries:


  • Thailand

International Drug Name Search

Sunday, 6 September 2009

Nitrazepam Teva




Nitrazepam Teva may be available in the countries listed below.


Ingredient matches for Nitrazepam Teva



Nitrazepam

Nitrazepam is reported as an ingredient of Nitrazepam Teva in the following countries:


  • Belgium

International Drug Name Search

Saturday, 5 September 2009

Flumazenil Pharmaselect




Flumazenil Pharmaselect may be available in the countries listed below.


Ingredient matches for Flumazenil Pharmaselect



Flumazenil

Flumazenil is reported as an ingredient of Flumazenil Pharmaselect in the following countries:


  • Slovakia

International Drug Name Search

Tuesday, 25 August 2009

Cyflee




Cyflee may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Cyflee



Cythioate

Cythioate is reported as an ingredient of Cyflee in the following countries:


  • Luxembourg

  • Netherlands

International Drug Name Search

Thursday, 20 August 2009

APC-Cetirizine




APC-Cetirizine may be available in the countries listed below.


Ingredient matches for APC-Cetirizine



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of APC-Cetirizine in the following countries:


  • Canada

International Drug Name Search

Neostesin




Neostesin may be available in the countries listed below.


Ingredient matches for Neostesin



Calcitonin

Calcitonin is reported as an ingredient of Neostesin in the following countries:


  • Greece

International Drug Name Search

Tuesday, 18 August 2009

Zitumex




Zitumex may be available in the countries listed below.


Ingredient matches for Zitumex



Piroxicam

Piroxicam is reported as an ingredient of Zitumex in the following countries:


  • Greece

International Drug Name Search

Saturday, 15 August 2009

Nor Fexodina




Nor Fexodina may be available in the countries listed below.


Ingredient matches for Nor Fexodina



Fexofenadine

Fexofenadine hydrochloride (a derivative of Fexofenadine) is reported as an ingredient of Nor Fexodina in the following countries:


  • El Salvador

International Drug Name Search

Friday, 14 August 2009

Trafermin (Genetical Recombination)




Trafermin (Genetical Recombination) may be available in the countries listed below.


Ingredient matches for Trafermin (Genetical Recombination)



Trafermin

Trafermin (Genetical Recombination) (JAN) is also known as Trafermin (Rec.INN)

International Drug Name Search

Glossary

JANJapanese Accepted Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 12 August 2009

Sequidot




Sequidot may be available in the countries listed below.


Ingredient matches for Sequidot



Estradiol

Estradiol is reported as an ingredient of Sequidot in the following countries:


  • Norway

Estradiol hemihydrate (a derivative of Estradiol) is reported as an ingredient of Sequidot in the following countries:


  • Austria

  • Germany

  • Sweden

  • Switzerland

Norethisterone

Norethisterone 17ß-acetate (a derivative of Norethisterone) is reported as an ingredient of Sequidot in the following countries:


  • Austria

  • Germany

  • Norway

  • Sweden

  • Switzerland

International Drug Name Search

Monday, 10 August 2009

Klorhexidin




Klorhexidin may be available in the countries listed below.


Ingredient matches for Klorhexidin



Chlorhexidine

Chlorhexidine diacetate (a derivative of Chlorhexidine) is reported as an ingredient of Klorhexidin in the following countries:


  • Norway

International Drug Name Search

Monday, 27 July 2009

Sistalgina




Sistalgina may be available in the countries listed below.


Ingredient matches for Sistalgina



Pramiverine

Pramiverine is reported as an ingredient of Sistalgina in the following countries:


  • Ecuador

International Drug Name Search

Sunday, 26 July 2009

Sertraniche




Sertraniche may be available in the countries listed below.


Ingredient matches for Sertraniche



Sertraline

Sertraline is reported as an ingredient of Sertraniche in the following countries:


  • Ireland

International Drug Name Search

Saturday, 25 July 2009

Geniol




Geniol may be available in the countries listed below.


Ingredient matches for Geniol



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Geniol in the following countries:


  • Argentina

International Drug Name Search

Friday, 24 July 2009

Nebivolol




In the US, Nebivolol (nebivolol systemic) is a member of the drug class cardioselective beta blockers and is used to treat High Blood Pressure and Mitral Valve Prolapse.

US matches:

  • Nebivolol

  • Nebivolol Hydrochloride

UK matches:

  • Nebivolol 5 mg tablets
  • Nebivolol 5mg Tablets
  • Nebivolol 5 mg tablets (SPC)
  • Nebivolol 5mg Tablets (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C07AB12

CAS registry number (Chemical Abstracts Service)

0099200-09-6

Chemical Formula

C22-H25-F2-N-O4

Molecular Weight

405

Therapeutic Categories

Antihypertensive agent

ß₁-Adrenergic blocking agent

Chemical Name

2H-1-Benzopyran-2-methanol, α,α'-[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-

Foreign Names

  • Nebivololum (Latin)
  • Nebivolol (German)
  • Nebivolol (French)
  • Nebivolol (Spanish)

Generic Names

  • Nebivolol (OS: BAN, USAN)
  • R 65824 (IS: Janssen)
  • Nebivolol Hydrochloride (OS: BANM)
  • R 67555 (IS)

Brand Names

  • Bystolic
    Forest, United States


  • Ebivol
    Actavis Group, Poland


  • Lovispes
    Specifar, Lithuania; Specifar, Latvia


  • Nebicard
    Hexal, Latvia; Sandoz, Lithuania; Torrent, Vietnam


  • Nebilet
    Adcock Ingram Pharmaceuticals, South Africa


  • Nebiloc
    Menarini, Costa Rica; Menarini, Dominican Republic; Menarini, Guatemala; Menarini, Honduras; Menarini, Nicaragua; Menarini, Panama; Menarini, El Salvador


  • Nebilox
    Menarini, Luxembourg


  • Nebispes
    Nycomed, Lithuania; Specifar, Latvia


  • Nebivolol AL
    Aliud, Germany


  • Nebivolol EG
    Eurogenerics, Luxembourg


  • Nebivolol Hexal
    Hexal, Luxembourg


  • Nemirostad
    Stada, Lithuania


  • Nobiten
    Menarini, Luxembourg


  • Nodon
    Cadila, India


  • Bivol
    Specifar, Greece


  • Conébilox (Nebivolol and Hydrochlorothiazide)
    Negma, France


  • Hypoloc
    Berlin-Chemie, Germany; Menarini, Austria; Menarini, Finland; Menarini, Luxembourg; Menarini International Operations S.A, Denmark


  • Lobibeta
    Alet Pharmaceuticals, Greece


  • Lobivon
    Berlin-Chemie, Germany; Menarini, Spain; Menarini, Greece; Menarini, Italy


  • Nebicard
    Torrent, Myanmar


  • Nebicur
    Med-One, Greece


  • Nebilet
    A. Menarini, United Kingdom; Berlin Chemie, Bosnia & Herzegowina; Berlin-Chemie, Czech Republic; Berlin-Chemie, Germany; Berlin-Chemie, Croatia (Hrvatska); Berlin-Chemie, Hungary; Berlin-Chemie, Poland; Berlin-Chemie, Romania; Berlin-Chemie, Serbia; Berlin-Chemie, Russian Federation; Berlin-Chemie, Slovakia; Biotoscana, Colombia; Dr. Fisher, Netherlands; Euro, Netherlands; Labomed, Chile; Leti, Venezuela; Medcor, Netherlands; Menarini, Argentina; Menarini, Switzerland; Menarini, Costa Rica; Menarini, Dominican Republic; Menarini, Estonia; Menarini, Guatemala; Menarini, Honduras; Menarini, Ireland; Menarini, Lithuania; Menarini, Latvia; Menarini, Malta; Menarini, Nicaragua; Menarini, Netherlands; Menarini, Panama; Menarini, Portugal; Menarini, Singapore; Menarini, El Salvador; Menarini, Thailand; Sanolabor, Slovenia


  • Nebilox
    Berlin-Chemie, Germany; GlaxoSmithKline, Italy


  • Nébilox
    Negma, France


  • Nebivolol AAA
    AAA-Pharma, Germany


  • Nebivolol AbZ
    AbZ, Germany


  • Nebivolol Actavis
    Actavis, Austria


  • Nebivolol Axapharm
    Axapharm, Switzerland


  • Nebivolol Heumann
    Heumann, Germany


  • Nebivolol Hexal
    Hexal, Germany


  • Nebivolol Pliva
    Pliva, Croatia (Hrvatska); Pliva, Hungary


  • Nebivolol Sandoz
    Sandoz, Germany


  • Nebivolol Stada
    Stada, Austria; Stada, Germany


  • Nebivolol Streuli
    Streuli Pharma, Switzerland


  • Nebivolol
    Berlin-Chemie, Georgia


  • Nebivolol-1A Pharma
    1A Pharma, Germany; 1A Pharma, Latvia


  • Nebivolol-Acino
    Acino, Germany


  • Nebivolol-Actavis
    Actavis, Germany


  • Nebivolol-CT
    CT Arzneimittel, Germany


  • Nebivolol-ratiopharm
    Ratiopharm, Germany


  • Nebivolol-Teva
    Teva, Germany; Teva Pharma, Switzerland


  • Nemirostad
    Stada, Estonia; Stada, Latvia


  • Nevibolol-Mepha
    Mepha Pharma, Switzerland


  • Nibel
    Belupo, Croatia (Hrvatska)


  • Nobiten
    Menarini, Belgium


  • Nomexor
    Menarini, Austria


  • Noviblock
    Medicamerc, Greece


  • Temerit
    Menarini, France


  • Vasoxen
    I.E. Ulagay, Turkey

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
SPC Summary of Product Characteristics (UK)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 17 July 2009

Baypresol




Baypresol may be available in the countries listed below.


Ingredient matches for Baypresol



Nitrendipine

Nitrendipine is reported as an ingredient of Baypresol in the following countries:


  • Spain

International Drug Name Search

Turm




Turm may be available in the countries listed below.


Ingredient matches for Turm



Flunisolide

Flunisolide is reported as an ingredient of Turm in the following countries:


  • Italy

International Drug Name Search

Wednesday, 15 July 2009

Sorot




Sorot may be available in the countries listed below.


Ingredient matches for Sorot



Dequalinium Chloride

Dequalinium Chloride is reported as an ingredient of Sorot in the following countries:


  • Germany

International Drug Name Search

Friday, 10 July 2009

Salbutamol Renaudin




Salbutamol Renaudin may be available in the countries listed below.


Ingredient matches for Salbutamol Renaudin



Salbutamol

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Salbutamol Renaudin in the following countries:


  • France

International Drug Name Search

Tuesday, 7 July 2009

Oxiglutatione




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0027025-41-8

Chemical Formula

C20-H32-N6-O12-S2

Molecular Weight

612

Therapeutic Category

Ophthalmic agent

Chemical Names

N,N'-[Dithiobis[($IR$r)-1-[(carboxymethyl)carbamoyl]ethylene]]di-L-glutamine (WHO)

(2S)-2-amino-5-[[(2R)-3-[(2R)-2-[[(4S)-4-amino-5-hydroxy-5-oxopentanoyl]amino]-3-(carboxymethylamino)-3-oxopropyl]disulfanyl-1-(carboxymethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid (IUPAC)

L-γ-Glutamyl-L-cysteinylglycine, (2->2')-disulfide

Foreign Names

  • Oxiglutationum (Latin)
  • Oxiglutation (German)
  • Oxiglutatione (French)
  • Oxiglutationa (Spanish)

Generic Names

  • Oxiglutatione (OS: JAN)
  • CCRIS 780 (IS)
  • Glutathione disulfide (IS)
  • GSSG (IS)
  • Oxidized glutathione (IS)

Brand Names

  • BSS Plus
    Alcon Nippon, Japan


  • Opeaqua
    Showa Yakuhin Kako, Japan


  • Opeguard Neo
    Senju Seiyaku, Japan

International Drug Name Search

Glossary

IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday, 6 July 2009

Metadate CD


Metadate CD is a brand name of methylphenidate, approved by the FDA in the following formulation(s):


METADATE CD (methylphenidate hydrochloride - capsule, extended release; oral)



  • Manufacturer: UCB INC

    Approval date: February 19, 2006

    Strength(s): 50MG, 60MG [RLD]

Has a generic version of Metadate CD been approved?


No. There is currently no therapeutically equivalent version of Metadate CD available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Metadate CD. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Methylphenidate modified release formulations
    Patent 6,344,215
    Issued: February 5, 2002
    Inventor(s): Marie J.; Bettman & Phillip J.; Percel & Dan L.; Hensley & Krishna S.; Vishnupad & Gopi M.; Venkatesh
    Assignee(s): Eurand America, Inc.
    A pharmaceutical MR (modified release) multiparticulate dosage form such as a capsule (once-a-day MR Capsule) of Methylphenidate indicated for the treatment of children with attention deficit hyperactivity disorder (ADHD), capable of delivering a portion of the dose for rapid onset of action and the remainder of the dose in a controlled manner for about 12 hours, is composed of a multitude of multicoated particles made of two populations of drug layered beads, IR (immediate release) and ER (extended release) Beads. The IR beads preferably are made by layering an aqueous solution comprising a drug and a binder on to non-pareil sugar spheres and then applying a seal coat to the drug coated cores. The ER Beads are made by applying an extended release coating of a water insoluble dissolution rate controlling polymer such as ethylcellulose to IR Beads. The MR Capsules are manufactured by filling IR and ER Beads in a proper ratio; the dose and the ratio required for an efficacious, cost effective and patient compliant treatment of children with ADHD were determined from extensive clinical investigations and in vitro- in vivo correlations performed as per FDA Guidelines, Guidance for Industry: Extended Release Oral Dosage Forms.
    Patent expiration dates:

    • October 27, 2020
      ✓ 
      Drug product



See also...

  • Metadate CD Controlled-Release Capsules Consumer Information (Wolters Kluwer)
  • Metadate CD Consumer Information (Cerner Multum)
  • Metadate CD Advanced Consumer Information (Micromedex)
  • Methylphenidate Consumer Information (Drugs.com)
  • Methylphenidate Consumer Information (Wolters Kluwer)
  • Methylphenidate Chewable Tablets Consumer Information (Wolters Kluwer)
  • Methylphenidate Controlled-Release Capsules Consumer Information (Wolters Kluwer)
  • Methylphenidate Controlled-Release Tablets Consumer Information (Wolters Kluwer)
  • Methylphenidate Extended-Release Capsules Consumer Information (Wolters Kluwer)
  • Methylphenidate Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Methylphenidate Solution Consumer Information (Wolters Kluwer)
  • Methylphenidate System Consumer Information (Wolters Kluwer)
  • Methylphenidate Consumer Information (Cerner Multum)
  • Methylphenidate transdermal Consumer Information (Cerner Multum)
  • Methylphenidate Oral, Transdermal Advanced Consumer Information (Micromedex)
  • Methylphenidate Transdermal Advanced Consumer Information (Micromedex)
  • Methylphenidate Hydrochloride AHFS DI Monographs (ASHP)

Sunday, 5 July 2009

Didronate +Calcium




Didronate +Calcium may be available in the countries listed below.


Ingredient matches for Didronate +Calcium



Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Didronate +Calcium in the following countries:


  • Finland

Etidronic Acid

Etidronic Acid disodium salt (a derivative of Etidronic Acid) is reported as an ingredient of Didronate +Calcium in the following countries:


  • Finland

International Drug Name Search

Saturday, 4 July 2009

Sinakort-A




Sinakort-A may be available in the countries listed below.


Ingredient matches for Sinakort-A



Triamcinolone

Triamcinolone 16α,17α-acetonide (a derivative of Triamcinolone) is reported as an ingredient of Sinakort-A in the following countries:


  • Turkey

International Drug Name Search

Spiramycin Ogb Dexa




Spiramycin Ogb Dexa may be available in the countries listed below.


Ingredient matches for Spiramycin Ogb Dexa



Spiramycin

Spiramycin is reported as an ingredient of Spiramycin Ogb Dexa in the following countries:


  • Indonesia

International Drug Name Search

Thursday, 2 July 2009

Finasterida Alter




Finasterida Alter may be available in the countries listed below.


Ingredient matches for Finasterida Alter



Finasteride

Finasteride is reported as an ingredient of Finasterida Alter in the following countries:


  • Portugal

  • Spain

International Drug Name Search

Sunday, 28 June 2009

Artrait




Artrait may be available in the countries listed below.


Ingredient matches for Artrait



Methotrexate

Methotrexate is reported as an ingredient of Artrait in the following countries:


  • Argentina

International Drug Name Search

Thursday, 25 June 2009

Ivyphenicol




Ivyphenicol may be available in the countries listed below.


Ingredient matches for Ivyphenicol



Chloramphenicol

Chloramphenicol is reported as an ingredient of Ivyphenicol in the following countries:


  • Ethiopia

International Drug Name Search

Sunday, 21 June 2009

Biofed-PE


Generic Name: pseudoephedrine and triprolidine (try PROE li deen and soo doe e FED rin)

Brand Names: A-Phedrin, Allerfrim, Allerphed, Altafed, Aphedrid, Aprodine, Biofed-PE, Genac, Histafed, Pediatex TD, Tripohist D, Vi-Sudo, Zymine-D


What is Biofed-PE (pseudoephedrine and triprolidine)?

Triprolidine is an antihistamine that reduces the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.


Pseudoephedrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).


The combination of pseudoephedrine and triprolidine is used to treat sneezing, cough, runny or stuffy nose, itchy or watery eyes, hives, skin rash, itching, and other symptoms of allergies and the common cold.


Pseudoephedrine and triprolidine may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about Biofed-PE (pseudoephedrine and triprolidine)?


Do not give this medication to a child younger than 2 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. Do not use any other over-the-counter cold, allergy, or sleep medication without first asking your doctor or pharmacist. If you take certain products together you may accidentally take too much of a certain drug. Read the label of any other medicine you are using to see if it contains an antihistamine or decongestant. Do not use a cough or cold medicine if you have used an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate) within the past 14 days. Serious, life-threatening side effects can occur if you take cough or cold medicine before the MAO inhibitor has cleared from your body. Pseudoephedrine and triprolidine can cause side effects that may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be awake and alert. Avoid drinking alcohol. It can increase some of the side effects of this medication.

What should I discuss with my healthcare provider before taking Biofed-PE (pseudoephedrine and triprolidine)?


Do not use a cough or cold medicine if you have used an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate) within the past 14 days. Serious, life-threatening side effects can occur if you take cough or cold medicine before the MAO inhibitor has cleared from your body.

Ask a doctor or pharmacist if it is safe for you to take pseudoephedrine and triprolidine if you have:


  • kidney disease;


  • diabetes;




  • glaucoma;




  • heart disease or high blood pressure;




  • diabetes;




  • a thyroid disorder;




  • an enlarged prostate; or




  • problems with urination.




This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. Pseudoephedrine and triprolidine can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

Artificially-sweetened liquid forms of cold medicine may contain phenylalanine. This would be important to know if you have phenylketonuria (PKU). Check the ingredients and warnings on the medication label if you are concerned about phenylalanine.


How should I take Biofed-PE (pseudoephedrine and triprolidine)?


Use this medication exactly as directed on the label, or as it has been prescribed by your doctor. Do not use the medication in larger amounts, or use it for longer than recommended. Cold medicine is usually taken only for a short time until your symptoms clear up.


Do not give this medication to a child younger than 2 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. Take this medicine with a full glass of water. Do not crush, chew, or break an extended-release tablet. Swallow the pill whole. It is specially made to release medicine slowly in the body. Breaking or opening the pill would cause too much of the drug to be released at one time.

Measure the liquid form of this medicine with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.


Talk with your doctor if your symptoms do not improve after 7 days of treatment, or if you have a fever with a headache, cough, or skin rash.

If you need to have any type of surgery, tell the surgeon ahead of time if you have taken a cold medicine within the past few days.


This medication can cause you to have unusual results with allergy skin tests. Tell any doctor who treats you that you are taking an antihistamine.


Store the medication at room temperature away from moisture and heat.

What happens if I miss a dose?


Since cold or allergy medicine is usually taken only as needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at your next regularly scheduled time. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine.

Overdose symptoms may include feeling restless or nervous, nausea, vomiting, stomach pain, dizziness, drowsiness, dry mouth, warmth or tingly feeling, or seizure (convulsions).


What should I avoid while taking Biofed-PE (pseudoephedrine and triprolidine)?


This medication can cause side effects that may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be awake and alert. Avoid drinking alcohol. It can increase some of the side effects of this medication.

Avoid taking diet pills, caffeine pills, or other stimulants (such as ADHD medications) without your doctor's advice. Taking a stimulant together with a decongestant can increase your risk of unpleasant side effects.


Do not use any other over-the-counter cold, allergy, or sleep medication without first asking your doctor or pharmacist. If you take certain products together you may accidentally take too much of a certain drug. Read the label of any other medicine you are using to see if it contains an antihistamine or decongestant.

Biofed-PE (pseudoephedrine and triprolidine) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have any of these serious side effects:

  • fast, pounding, or uneven heartbeat;




  • confusion, hallucinations, unusual thoughts or behavior;




  • severe dizziness, anxiety, restless feeling, or nervousness;




  • increased blood pressure (severe headache, blurred vision, trouble concentrating, chest pain, numbness, seizure);




  • confusion, hallucinations, unusual thoughts or behavior;




  • easy bruising or bleeding, unusual weakness, fever, chills, body aches, flu symptoms; or




  • urinating less than usual or not at all.



Less serious side effects may include:



  • blurred vision;




  • dry mouth;




  • nausea, stomach pain, constipation;




  • mild loss of appetite, stomach upset;




  • warmth, tingling, or redness under your skin;




  • sleep problems (insomnia);




  • restless or excitability (especially in children);




  • skin rash or itching;




  • dizziness, drowsiness;




  • problems with memory or concentration; or




  • ringing in your ears.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Biofed-PE (pseudoephedrine and triprolidine)?


Tell your doctor if you regularly use other medicines that make you sleepy (such as narcotic pain medicine, sleeping pills, muscle relaxers, and medicine for seizures, depression, or anxiety). They can add to sleepiness caused by pseudoephedrine and triprolidine.

Tell your doctor about all other medications you use, especially:



  • medicines to treat high blood pressure;




  • a diuretic (water pill);




  • medication to treat irritable bowel syndrome;




  • bladder or urinary medications such as oxybutynin (Ditropan, Oxytrol) or tolterodine (Detrol);




  • aspirin or salicylates (such as Disalcid, Doan's Pills, Dolobid, Salflex, Tricosal, and others);




  • a beta-blocker such as atenolol (Tenormin, Tenoretic), carvedilol (Coreg), labetalol (Normodyne, Trandate), metoprolol (Lopressor, Toprol), nadolol (Corgard), propranolol (Inderal, InnoPran), sotalol (Betapace), and others; or




  • antidepressants such as amitriptyline (Elavil), clomipramine (Anafranil), imipramine (Janimine, Tofranil), and others.



This list is not complete and there may be other drugs that can interact with pseudoephedrine and triprolidine. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.



More Biofed-PE resources


  • Biofed-PE Side Effects (in more detail)
  • Biofed-PE Use in Pregnancy & Breastfeeding
  • Biofed-PE Drug Interactions
  • Biofed-PE Support Group
  • 0 Reviews for Biofed-PE - Add your own review/rating


  • Actifed Consumer Overview

  • Actifed MedFacts Consumer Leaflet (Wolters Kluwer)

  • Allerfrim Liquid MedFacts Consumer Leaflet (Wolters Kluwer)

  • Tripohist D Prescribing Information (FDA)



Compare Biofed-PE with other medications


  • Cold Symptoms
  • Hay Fever


Where can I get more information?


  • Your pharmacist can provide more information about pseudoephedrine and triprolidine.

See also: Biofed-PE side effects (in more detail)